Dehydro ivabradine CAS: 1086026-31-4

Product Parameters
Catalog No. BK206L
CAS.RN 1086026-31-4
Molecular Formula C27H34N2O5
Molecular Weight 466.57 g/mol
Purity NLT 98%
Synonyms Dehydroivabradine
Product Overview

Dehydro-ivabradine is an important pharmaceutical intermediate widely used in the research and development and production of cardiovascular drugs. It is mainly used to synthesize ivabradine-like drugs. It has good chemical stability and reactivity and is suitable for research and development, pilot-scale, pilot-scale and large-scale production stages. It is one of the important raw materials for pharmaceutical companies to carry out process development and product transformation.

Applications
  • Synthesis of cardiovascular drug intermediates
  • Process development of ivabradine-like drugs
  • Drug molecular structure modification research
  • Customized pharmaceutical synthesis services
  • Process route optimization and scale-up production
Quality & Supply Capability

English Name: Dehydro ivabradine Properties: White to off-white crystalline powder with a stable chemical structure, readily soluble in organic solvents, suitable for various organic synthesis reactions, possessing good reactivity and purity control capabilities. Storage Recommendations: Store in a sealed, light-protected, and dry place, subject to the specific COA/MSDS. Supply Capabilities: Samples, gram-level, kilogram-level, commercial batches. Packaging Specifications: Aluminum foil bags, fluorinated bottles, cardboard drums, customized packaging. Document Support: COA, MSDS, HPLC, NMR, etc. We provide a full-process service from sample supply to small-scale preparation, pilot-scale amplification, and customized batch production. We can flexibly adjust the supply plan according to the customer's specific requirements for purity, impurity control, packaging specifications, delivery cycle, and quality documents. We also provide comprehensive technical support from laboratory R&D to scale-up production, helping customers efficiently advance process development, route optimization, and project transformation.

Why Choose Bioncan

Focused on pharmaceutical intermediates, possessing a rich product portfolio and accumulated technological expertise. Full-scale supply capabilities to meet diverse needs from laboratory to commercial production. Comprehensive quality control documentation to ensure traceable and verifiable product quality. Flexible response to customized requirements, supporting personalized specifications and special packaging. Supporting process optimization and scale-up technologies to enhance customer R&D efficiency and production stability.

Intermediates of Ivabradine hydrochloride
Catalog No. Product Name CAS
BA05GW Ivabradine hydrochloride API 148849-67-6
BK82Q4 4,5-Dimethoxy-1-cyanobenzocyclobutane 35202-54-1
BK598V (1S)-4,5-Dimethoxy-1-[(methylamino)methyl]benzocyclobutane hydrochloride 866783-13-3
BK33FJ 7,8-Dimethoxy-1,3-dihydro-2H-3-benzazepin-2-one 73942-87-7
BK56VJ (S)-1-(3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)-N-methylmethanamine 866783-12-2
BK206L Dehydro ivabradine 1086026-31-4
BK4YJ2 N-(3-Bromopropyl)-Phthalimide 5460-29-7
BK3E8G 2,2-Dimethoxy acetaldehyde 51673-84-8
BK40K6 1,1-Diethoxyethene 2678-54-8
BK9D07 The metabolite of ivabradine 215935-23-2
BK752T 3,4-DimethoxyPhenylethylamine 120-20-7
BK364P C-(3,4-DIMETHOXY-BICYCLO[4.2.0]OCTA-1(6),2,4-TRIEN-7-YL)-METHYLAMINE 73344-75-9
BK96F9 (3,4-DiMethyoxy-bicyclo(4,2,0)octa-1(6),2,4-trien-7-ylMethyl)-carbaMic acid ethyl ester 148870-55-7
BK8YQ4 7,8-Dimethoxy-3-(3-iodopropyl)-1,3-dihydro-2H-3-benzazepin-2-one 148870-57-9
BK7CK9 Propanedioic acid, 2-​(2-​bromo-​4,​5-​dimethoxyphenyl)​-​, 1,​3-​dimethyl ester 1069115-30-5
BK1AT9 Bicyclo[4.2.0]​octa-​1,​3,​5-​triene-​7,​7-​dicarboxylic acid, 3,​4-​dimethoxy-​, 7,​7-​dimethyl ester 1069115-32-7
BK9Z16 7,8-Dimethoxy-1,3-dihydro-2H-3-benzazepin-2-one hydrochloride 163629-94-5
BK813C 4,5-diMethoxy-N-Methyl-1,2-dihydrocyclobutabenzene-1-carboxaMide 1206230-27-4
BK2BU0 3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methylamino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one 148870-58-0
BK2PD7 3-(3-(((S)-4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(methyl)amino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one hydrochloride 1393427-01-4
BK5KH5 (S)-3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methylamino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one 1393427-02-5
BK45M1 (S)-3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(2,2-dimethoxyethyl)amino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one 1393427-03-6
BK5EL6 (3,4-DiMethoxyphenyl)acetyl chloride 10313-60-7
BK8E10 7,8-Dimethoxy-3-(3-((2-(3,4-dimethoxyphenyl)acetyl)(methyl)amino)propyl)-2,3-dihydro-1H-benzo[d]azepin-2-one 1393427-04-7
BK2YU2 4,5-DIBROMOVERATROLE 37895-73-1
BK67FH (S)-3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(methyl)amino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one 1-oxide 1132079-01-6
BK2Z7N (S)-3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(methyl)amino)propyl)-7,8-dimethoxy-2-oxo-2,3-dihydro-1H-benzo[d]azepin-1-ium chloride 1246638-10-7
BK0F52 Bicyclo[4.2.0]​octa-​1,​3,​5-​triene-​7-​carboximidamide, 3,​4-​dimethoxy-​N-​methyl-​N-​[3-​(1,​2,​4,​5-​tetrahydro-​7,​8-​dimethoxy-​2-​oxo-​3H-​3-​benzazepin-​3-​yl)​propyl]​- 1246672-58-1
BK8Q64 7,8-Dimethoxy-3-(3-((2-(3,4-dimethoxyphenyl)ethyl)amino)propyl)-2,3-dihydro-1H-benzo[d]azepin-2-one 98062-25-0
BK85JV 3-chloro-N-{[(7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl}-N-methyl-1-propanamine 1031767-71-1
BK5F84 (S)-N-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)-N-methyl-3-(7,8-dimethoxy-2-oxo-2,3-dihydro-1H-benzo[d]azepin-3-yl)propan-1-aminium chloride 1325209-22-0
BK515P (S)-3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(methyl)amino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one sulfate 1325209-23-1
BK5J56 (S)-3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(methyl)amino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one mesylate 1325209-25-3
BK32MX (S)-3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(methyl)amino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one hydrobromide 1325209-24-2
BK1E79 (S)-3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(methyl)amino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one phosphate 1325209-26-4
BK36R2 (S)-3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(methyl)amino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one acetate 1325209-27-5
Products are offered for research, development, or industrial use only.
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
Online Consulting

For quotation, inventory, samples, COA, MSDS, or custom synthesis support for CAS 1086026-31-4, please submit your requirements. We will respond according to purity, quantity, delivery timeline, and documentation needs.